Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EBIT Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 0.9721.2241.65-15.6018.78

What is the latest EBIT Growth ratio of MANKIND PHARMA ?

The latest EBIT Growth ratio of MANKIND PHARMA is 0.97 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar20260.97
Mar202521.22
Mar202441.65
Mar2023-15.60
Mar202218.78

How is EBIT Growth of MANKIND PHARMA Trending?

Years EBIT Growth % Change
Mar2026 0.97
-95.43
Mar2025 21.22
-49.05
Mar2024 41.65
Positive
Mar2023 -15.6
Negative
Mar2022 18.78 -

Other Financial Ratios of MANKIND PHARMA


Compare EBIT Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹92,842.4 Cr -0.8% -6.3% -12.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -1.5% 15.1% Stock Analytics
DIVIS LABORATORIES ₹244,223.0 Cr -3% 8.3% 52.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹183,453.0 Cr -2.2% -1.5% 35% Stock Analytics
CIPLA ₹109,849.0 Cr -0.6% -4.9% -13% Stock Analytics
DR REDDYS LABORATORIES ₹95,591.8 Cr 0.2% -3.9% -11.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.8%

-6.3%

-12.3%

SENSEX

-1.6%

-4.7%

-8.3%


You may also like the below Video Courses